Current perspectives on familial Mediterranean fever

Area of Science:

• Genetics and Molecular Biology
• Immunology
• Rheumatology

Background:

• Familial Mediterranean Fever (FMF) is a genetic autoinflammatory disorder.
• The MEFV gene, identified two decades ago, is responsible for FMF.
• Recent research has significantly advanced the understanding of FMF pathogenesis.

Purpose of the Study:

• To review recent studies on FMF pathogenesis.
• To elucidate the role of MEFV gene mutations in FMF.
• To understand the molecular mechanisms underlying FMF and its complications.

Main Methods:

• Review of recent scientific literature on FMF.
• Analysis of mutation data in the MEFV gene, particularly in the B30.2 (SPRY) domain.
• Examination of genetic polymorphisms and their association with FMF and amyloidosis.

Main Results:

• Most FMF mutations occur in the B30.2 (SPRY) domain of pyrin, affecting IL-1beta activation and leading to inflammation.
• AA amyloidosis is uncommon in FMF patients lacking specific SAA1 gene polymorphisms.
• Elevated macrophage inflammatory protein-1alpha levels may enhance T-cell immunity during FMF attacks.

Conclusions:

• Further research is needed to define the impact of MEFV mutations on FMF progression.
• Understanding the pathophysiology in colchicine-unresponsive patients is crucial for developing new therapies.
• Novel therapeutic strategies may improve FMF management and patient prognosis.